Description
PHARMACY EMERGENCY MULTITRACE ORDER
First action · last action
2013-04-24 · 2013-04-24
Transactions
1
First transaction's obligation
$549
Base + all options value (sum of deltas)
$549
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
MICRO PURCHASE THRESHOLD
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-04-24+$549= $549
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-04-24 | +$549 | $549 | PHARMACY EMERGENCY MULTITRACE ORDER |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JTAPCFM4NSL4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26024P0343 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $10,312 | FY2024 |
| 36C24824P0748 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $56,559 | FY2024 |
| 36C25724P0104 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $41,571 | FY2024 |
| 36C24724P0133 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS | $10,393 | FY2024 |
| 36C24824P0161 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $27,010 | FY2024 |
| 36C24823P2639 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $31,862 | FY2023 |
Other recipients under 6505 from 636A6-CENTRAL IOWA HEALTH CARE SYSTEM (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26315P0304 | MCKESSON PLASMA AND BIOLOGICS LLC | 636A6-CENTRAL IOWA HEALTH CARE SYSTEM | $2,889 | FY2015 |
| VA26313J1390 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 636A6-CENTRAL IOWA HEALTH CARE SYSTEM | $875 | FY2013 |
| VA26313P1340 | GULF COAST PHARMACEUTICALS PLUS, LLC | 636A6-CENTRAL IOWA HEALTH CARE SYSTEM | $8,500 | FY2013 |
| VA26313F1287 | ACTELION PHARMACEUTICALS US, INC. | 636A6-CENTRAL IOWA HEALTH CARE SYSTEM | $25,305 | FY2013 |
| VA26313F1276 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 636A6-CENTRAL IOWA HEALTH CARE SYSTEM | $875 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26313P1347_3600_-NONE-_-NONE- · retrieved 2026-09-26.